Exploring preventive and treatment strategies for oral cancer: Modulation of signaling pathways and microbiota by probiotics

Gene. 2025 Jun 10:952:149380. doi: 10.1016/j.gene.2025.149380. Epub 2025 Mar 13.

Abstract

The evidence suggests that the microbiome plays a crucial role in cancer development. The oral cavity has many microorganisms that can influence oral cancer progression. Understanding the mechanisms and signaling pathways of the oral, gum, and teeth microbiome in tumor progression can lead to new treatment strategies. Probiotics, which are friendly microorganisms, have shown potential as anti-cancer agents. These positive characteristics of probiotic strains make them suitable for cancer prevention or treatment. The oral-gut microbiome axis supports health and homeostasis, and imbalances in the oral microbiome can disrupt immune signaling pathways, epithelial barriers, cell cycles, apoptosis, genomic stability, angiogenesis, and metabolic processes. Changes in the oral microbiome in oral cancer may suggest using probiotics-based treatments for their direct or indirect positive roles in cancer development, progression, and metastasis, specifically oral squamous cell carcinoma (OSCC). Here, reported relationships between probiotics, oral microbiota, and oral cancer are summarized.

Keywords: Immunotherapy; Microbiome; Oral cancer; Probiotics; Treatment.

Publication types

  • Review

MeSH terms

  • Animals
  • Carcinoma, Squamous Cell* / microbiology
  • Carcinoma, Squamous Cell* / prevention & control
  • Carcinoma, Squamous Cell* / therapy
  • Gastrointestinal Microbiome
  • Humans
  • Microbiota* / drug effects
  • Mouth / microbiology
  • Mouth Neoplasms* / microbiology
  • Mouth Neoplasms* / prevention & control
  • Mouth Neoplasms* / therapy
  • Probiotics* / pharmacology
  • Probiotics* / therapeutic use
  • Signal Transduction / drug effects